Search
Products
Community
Markets
News
Brokers
More
EN
Get started
Markets
/
Germany
/
ETF market
/
2B70
/
Analysis
iShares NASDAQ US Biotechnology UCITS ETF
2B70
Frankfurt Stock Exchange
2B70
Frankfurt Stock Exchange
2B70
Frankfurt Stock Exchange
2B70
Frankfurt Stock Exchange
Market closed
Market closed
No trades
See on Supercharts
Overview
Analysis
News
Ideas
Minds
Key stats
Assets under management (AUM)
467.14 M
EUR
Fund flows (1Y)
—
Dividend yield (indicated)
—
Discount/Premium to NAV
—
About iShares NASDAQ US Biotechnology UCITS ETF
Issuer
BlackRock, Inc.
Brand
iShares
Expense ratio
0.35%
Home page
ishares.com
Inception date
Oct 19, 2017
Index tracked
NASDAQ Biotechnology Index
Management style
Passive
ISIN
IE00BYXG2H39
The investment objective of the Fund is to seek to provide investors with a total return, taking into account both capital and income returns, which reflects the return of the NASDAQ Biotechnology Index.
Show more
Classification
Asset Class
Equity
Category
Sector
Focus
Health care
Niche
Biotechnology
Strategy
Exchange-specific
Weighting scheme
Market cap
Selection criteria
NASDAQ - listed
Returns
1 month
3 months
Year to date
1 year
3 years
5 years
Price performance
—
—
—
—
—
—
NAV total return
—
—
—
—
—
—
What's in the fund
As of June 17, 2024
Exposure type
Stocks
Bonds, Cash & Other
Health Technology
Stocks
99.32%
Health Technology
97.18%
Commercial Services
1.76%
Health Services
0.38%
Bonds, Cash & Other
0.68%
Mutual fund
0.31%
Cash
0.22%
Futures
0.15%
Stock breakdown by region
99%
0.3%
North America
99.69%
Europe
0.31%
Latin America
0.00%
Asia
0.00%
Africa
0.00%
Middle East
0.00%
Oceania
0.00%
Top 10 holdings
Dividends
Dividend payout history
Assets under management (AUM)
Fund Flows